Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01142271|
Recruitment Status : Unknown
Verified November 2011 by Sang-Uk Han, Ajou University School of Medicine.
Recruitment status was: Recruiting
First Posted : June 11, 2010
Last Update Posted : November 7, 2011
|Condition or disease||Intervention/treatment||Phase|
|Gastrectomy||Procedure: Billroth-I Procedure: Roux en Y||Phase 3|
Most common procedure for the resection of gastric cancers located in middle or lower stomach is distal subtotal gastrectomy. However, the optimal reconstruction procedure after that has still not to be established. Although B-I reconstruction is most common method due to the safety and simplicity, the duodenal fluid may reflux into the remnant stomach which may contribute to the mucosal injury to remnant stomach and esophagus. Roux en Y reconstruction may reduce the reflux to remnant stomach due to the length of Roux en Y limb, although it is more complicated procedure.
Therefore, we plan to collect 120 patients to compare the degree of reflux between Roux en Y and Billroth-I reconstructions after distal subtotal gastrectomy for gastric cancer. In addition, we compare the surgical outcome and quality of life between two groups.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy for Gastric Cancer Patients : Prospective Randomized Study|
|Study Start Date :||June 2010|
|Estimated Primary Completion Date :||May 2012|
|Estimated Study Completion Date :||May 2012|
Patients in this group should be underwent gastroduodenostomy as reconstruction procedure after standard distal subtotal gastrectomy with lymph node dissection.
Standard distal gastrectomy with D1 plus beta or D2 lymph node dissection would be performed for distal gastric cancer. After that, gastroduodenostomy should be performed by circular stapler. In addition, stapler sites were re-enforced.
Other Name: Gastroduodenostomy
Experimental: Roux en Y
Patients in this group should be underwent jejunojejunostomy and gastrojejunostomy as reconstruction procedure after standard distal gastrectomy.
Procedure: Roux en Y
Standard distal gastrectomy with D1 plus beta or D2 lymph node dissection would be performed for distal gastric cancer. After that, jejunojejunostomy and gastrojejunostomy should be performed by circular staplers. In addition, stapler sites were re-enforced.
Other Name: Gastrojejunostomy and jejunojejunostomy
- Reflux of bile content [ Time Frame: 6 months after surgery ]We estimate the degree of reflux by gastrofiberscopic findings using reflux score suggested by Romaganoli. In addition, histological finding of remnant stomach by endoscopic biopsy is also investigated. Reflux symptom is surveyed by Gastrointestinal Symptom Rating Scale.
- Quality of Life [ Time Frame: 6 months after surgery ]We investigate the quality of life with EORTC-C30, EORTC-STO22 questionnaire suggested by European Organization for Research and Treatment of Cancer (EORTC).
- Morbidity [ Time Frame: 2 month after surgery ]We investigate the occurrence of complication during recovery after surgery.
- Anastomotic time [ Time Frame: Day 1 ]We estimate anastomosis time
- Nutritional state [ Time Frame: 6 month after surgery ]We estimate Albumin, transferrin, lymphocyte, body weight
- Mortality [ Time Frame: 2 month after operation ]We investigate the occurrence of operation-related death during recovery after surgery.
- Operation time [ Time Frame: Day 1 ]We estimate total operation time.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01142271
|Contact: Hoon Hur, M.D.||+email@example.com|
|Contact: Sang-Uk Han, M.D.||+firstname.lastname@example.org|
|Korea, Republic of|
|Ajou University Hospital||Recruiting|
|Suwon, Korea, Republic of, 422-749|
|Contact: Hoon Hur, M.D. +82-31-219-5207 email@example.com|
|Contact: Jun Young Kim, M.D. +82-31-219-5206 firstname.lastname@example.org|
|Principal Investigator: Sang-Uk Han, M.D., Ph.D.|
|Sub-Investigator: Hoon Hur, M.D.|
|Sub-Investigator: Young Bae Kim, M.D.|
|Sub-Investigator: Jun Young Kim, M.D.|
|Sub-Investigator: Sun Mi Uhm, N.R.|
|Principal Investigator:||Sang-Uk Han, M.D., Ph D.||Department of Surgery, Ajou University School of Medicine|
|Study Director:||Hoon Hur, M.D.||Department of Surgery, Ajou University School of Medicine|